Inactive Instrument

Other languages Parnell Pharmaceuticals Holdings Ltd Nasdaq

Equities

AU0000XINEU9

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Parnell Pharmaceuticals : Introduces Two New Sedation Products to Pet Care Product Line	May. 15
Parnell Pharmaceuticals : Welcomes Dr. Chelsie Estey as Vice President of U.S. Pet Care	Mar. 07
Parnell Pharmaceuticals : Adds Three Experts to Leadership Team	23-05-30
Parnell Pharmaceuticals : Two New Territory Business Managers Help Parnell Better Serve Producers and Veterinarians	23-05-30
Parnell Pharmaceuticals Holdings Ltd Announces Extension of Rights Offering	23-01-06
Parnell Pharmaceuticals Holdings Ltd Announces Commencement of Rights Offering	22-12-06
Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum	22-06-21
Parnell Pharmaceuticals Holdings Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-06-20
DW Healthcare Partners V, L.P. managed by DW Healthcare Partners completed the acquisition of a 29% stake in Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARN.F) for $2.5 million	21-01-27
DW Healthcare Partners V, L.P. managed by DW Healthcare Partners made an offer to acquire Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARN.F) for $7.2 million.	20-12-20
Parnell Pharmaceuticals Announces Nomovid Antiviral Nasal Spray	20-09-23
Parnell Pharmaceuticals Holdings Ltd Reports Earnings Results for the Half Year Ended June 30, 2019	19-10-13
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Full Year Ended 31 December 2018; Provides Earnings Guidance for the Year 2019	19-04-04
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Nine Months Ended September 30, 2018; Revises Revenue Guidance for the Year 2018	18-11-02
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2018; Revised Earnings Guidance for the Full Year 2018	18-08-03
Parnell Pharmaceuticals Holdings Ltd Reports Audited Earnings Results for the First Quarter Ended March 31, 2018; Revises Earnings Guidance for the Year 2018	18-04-28
Parnell Pharmaceuticals Holdings Ltd. Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2017; Provides Earnings Guidance for the Year 2017	17-08-17
Certain Ordinary Shares of Parnell Pharmaceuticals Holdings Ltd are subject to a Lock-Up Agreement Ending on 30-MAR-2017.	17-03-29
Certain Options of Parnell Pharmaceuticals Holdings Ltd are subject to a Lock-Up Agreement Ending on 30-MAR-2017.	17-03-29
Certain Warrants of Parnell Pharmaceuticals Holdings Ltd are subject to a Lock-Up Agreement Ending on 30-MAR-2017.	17-03-29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Parnell Pharmaceuticals Holdings Ltd Nasdaq

Equities

AU0000XINEU9

Other languages

Filters